Publications by authors named "Giles Davis"

Claim this Profile
P
Preclinical Immunogenicity and Efficacy Studies for Therapeutic Vaccines for Human Papillomavirus-Type-16-Associated Cancer.
Mohsen Mohammadi, Amara Saha, Wynetta Giles-Davis, Zhiquan Xiang, Mikhail Novikov

Vaccines (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8 T cell therapy for melanoma.
Mohadeseh Hasanpourghadi, Arezki Chekaoui, Sophia Kurian, Raj Kurupati, Robert Ambrose, Wynetta Giles-Davis

Mol Ther Oncolytics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19.
Mohadeseh Hasanpourghadi, Mikhail Novikov, Robert Ambrose, Arezki Chekaoui, Dakota Newman, Wynetta Giles-Davis

Microbes Infect· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing CD8 T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy.
Ying Zhang, Raj Kurupati, Ling Liu, Xiang Yang Zhou, Gao Zhang, Wynetta Giles-Davis

Cancer Cell· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.
Larissa H Haut, Amanda L Gill, Raj K Kurupati, Ang Bian, Yan Li, Wynetta Giles-Davis

Hum Gene Ther Methods· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of the relative frequencies of reported adverse events associated with NSAID administration in dogs and cats in the United Kingdom.
James R Hunt, Rachel S Dean, Giles N D Davis, Joanna C Murrell

Vet J· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events relating to dispensing errors.
Gillian Diesel, Giles Davis

Vet Rec· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the VMD's product information database.
Suzanne Eckford, Giles Davis

Vet Rec· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Pexion tablets for dogs.
Giles Davis, Gillian Diesel

Vet Rec· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting suspected adverse events.
Giles Davis

Vet Rec· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virus.
Dongming Zhou, Te-Lang Wu, Kristel L Emmer, Raj Kurupati, Steven Tuyishime, Wynetta Giles-Davis

Mol Ther· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrepancies in the Controlled Drug register due to the use of products marketed in multi-dose presentations.
Giles Davis

Vet Rec· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice.
Marcio O Lasaro, Marina Sazanovich, Wynetta Giles-Davis, Paulus Mrass, Ralph M Bunte

Mol Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice.
Hua Li, Steven Tuyishime, Te-Lang Wu, Wynetta Giles-Davis, Dongming Zhou

Mol Ther· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques.
Marcio O Lasaro, Larissa H Haut, Xiangyang Zhou, Zhiquan Xiang, Dongming Zhou, Wynetta Giles-Davis

Mol Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust genital gag-specific CD8+ T-cell responses in mice upon intramuscular immunization with simian adenoviral vectors expressing HIV-1-gag.
Larissa H Haut, Shih W Lin, Nia Tatsis, Lauren J DiMenna, Wynetta Giles-Davis

Eur J Immunol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector.
Dongming Zhou, Xiangyang Zhou, Ang Bian, Hua Li, Heng Chen, Wynetta Giles-Davis

Nat Protoc· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway.
Lauren DiMenna, Brian Latimer, Elizabeth Parzych, Larissa H Haut, Katrin Töpfer, Wynetta Giles-Davis

J Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer.
Hua Li, Shih-Wen Lin, Wynetta Giles-Davis, Yan Li, Dongming Zhou

Mol Ther· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens.
Nia Tatsis, Marcio O Lasaro, Shih-Wen Lin, Larissa H Haut, Zhi Q Xiang, Wynetta Giles-Davis

J Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.
Kimberly McCoy, Nia Tatsis, Birgit Korioth-Schmitz, Marcio O Lasaro, Scott E Hensley, Wynetta Giles-Davis

J Virol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.
Hua Li, Samuel L Murphy, Wynetta Giles-Davis, Shyrie Edmonson, Zhiquan Xiang

Mol Ther· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.
Scott E Hensley, Ann S Cun, Wynetta Giles-Davis, Yan Li, Zhiquan Xiang

Mol Ther· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimpanzee-origin adenovirus vectors as vaccine carriers.
N Tatsis, L Tesema, E R Robinson, W Giles-Davis, K McCoy

Gene Ther· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.
Scott E Hensley, Wynetta Giles-Davis, Kimberly C McCoy, Wolfgang Weninger, Hildegund C J Ertl

J Immunol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis